Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Thermo Fisher Scientific (TMO) stock gains as the company beats Q4 2024 expectations and sets 2025 earnings outlook in line ...

LEAP 2025 promises even more with 1,800 global tech brands, 680 startups, and 1,000 expert speakers showcasing next-gen ...

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and ...

Thermo Fisher Scientific posted higher profit and revenue in the fourth quarter, and expressed confidence for the year ahead. The Waltham, Mass., maker of microscopes and other life-sciences and ...

Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.

Core organic revenue rose 5%. "We are in a great position to deliver excellent performance in 2025," Chief Executive Marc Casper said.

Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.